Molecular docking can identify compounds in A. absinthium root extract (AARE) that bind strongly to key therapeutic targets, including enzymes involved in oxidative stress (e.g., NADPH oxidase), cancer proliferation (e.g., Topoisomerase IIα), bacterial survival (e.g., DNA Gyrase B), and diabetes (e.g., α-glucosidase) [14]. This evidence concerns the gene FMO5 and cancer.